George Frey, MD, is also Aclarion’s first key opinion leader to onboard Nociscan to a hospital MRI. The software leverages augmented intelligence.
“Treating patients effectively starts with an informed understanding of where their pain is coming from,” Dr. Frey said in the release. “In my experience with Nociscan, objectively measuring the biomarker content corelated with pain within a disc that may look healthy on an MRI, adds to my knowledge of how to treat that patient.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
